Fulltext

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

Bernard, L. ; Stern, R. ; Lew, D. ; Hoffmeyer, P.

In: Clinical Infectious Diseases, 2003, vol. 36, no. 9, p. -

Ajouter à la liste personnelle
    Titre
    • Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram
    Auteur
    • Bernard, L.. Division of Orthopaedic Surgery, Geneva, Switzerland
    • Stern, R.. Division of Orthopaedic Surgery, Geneva, Switzerland
    • Lew, D.. Division of Infectious Diseases, Geneva University Hospital, Geneva, Switzerland
    • Hoffmeyer, P.. Division of Orthopaedic Surgery, Geneva, Switzerland
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Clinical Infectious Diseases, 2003, vol. 36, p. 9. The University of Chicago Press
    Autre version électronique
    Classification
    • Santé
    Identifiant OAI-PMH
    • oai:doc.rero.ch:299740
    Summary
    Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin reuptake inhibitor paroxitene, this report concerns a patient receiving citalopram who developed thrombocytopenia, serotonin syndrome, and lactic acidosis and died following long-term linezolid therapy